Stock Research for MRK

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

MRK Stock Chart & Research Data

The MRK chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the MRK chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


MRK Due diligence Resources & Stock Charts

The MRK stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View MRK Detailed Price Forecast - CNN Money CNN View MRK Detailed Summary - Google Finance
Yahoo View MRK Detailed Summary - Yahoo! Finance Zacks View MRK Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View MRK Trends & Analysis - Trade-Ideas Barrons View MRK Major Holders - Barrons
NASDAQ View MRK Call Transcripts - NASDAQ Seeking View MRK Breaking News & Analysis - Seeking Alpha
Spotlight View MRK Annual Report - CompanySpotlight.com OTC Report View MRK OTC Short Report - OTCShortReport.com
TradeKing View MRK Fundamentals - TradeKing Charts View MRK SEC Filings - Bar Chart
WSJ View Historical Prices for MRK - The WSJ Morningstar View Performance/Total Return for MRK - Morningstar
MarketWatch View the Analyst Estimates for MRK - MarketWatch CNBC View the Earnings History for MRK - CNBC
StockMarketWatch View the MRK Earnings - StockMarketWatch MacroAxis View MRK Buy or Sell Recommendations - MacroAxis
Bullish View the MRK Bullish Patterns - American Bulls Short Pains View MRK Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View MRK Stock Mentions - StockTwits PennyStocks View MRK Stock Mentions - PennyStockTweets
Twitter View MRK Stock Mentions - Twitter Invest Hub View MRK Investment Forum News - Investor Hub
Yahoo View MRK Stock Mentions - Yahoo! Message Board Seeking Alpha View MRK Stock Mentions - Seeking Alpha






Financial & Transaction Holdings

SECform4 View Insider Transactions for MRK - SECform4.com Insider Cow View Insider Transactions for MRK - Insider Cow
CNBC View MRK Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for MRK - OTC Markets
Yahoo View Insider Transactions for MRK - Yahoo! Finance NASDAQ View Institutional Holdings for MRK - NASDAQ


Stock Charts

FinViz View MRK Stock Insight & Charts - FinViz.com StockCharts View MRK Investment Charts - StockCharts.com
BarChart View MRK Stock Overview & Charts - BarChart Trading View View MRK User Generated Charts - Trading View


Latest Financial News for MRK

Merck (MRK) Stock Up So Far This Year on Keytruda Strength
Posted on Friday June 22, 2018

Merck's shares are up 8.4% this year driven by strong performance and positive regulatory updates related to its PD-1 inhibitor, Keytruda.


Is It Time To Sell Merck & Co Inc (NYSE:MRK) Based Off Its PE Ratio?
Posted on Friday June 22, 2018

I am writing today to help inform people who are new to the stock market and want to better understand how you can grow your money by investing in MerckRead More...


U.S. medical device firm electroCore IPO price set at $15/shr
Posted on Friday June 22, 2018

U.S. medical device maker electroCore Inc's initial public offering is expected to price at $15 per share, Chief Executive Officer Frank Amato told Reuters on Thursday. ElectroCore, which is backed by the venture capital arm of Merck & Co, is set to debut on the Nasdaq on Friday under the ticker symbol "ECOR".


Novo Nordisk Stock Rises 4% Over 2 Sessions
Posted on Thursday June 21, 2018

is riding the success of its experimental diabetes drug's positive test results, with the shares rising 1.65% Thursday to $46.40. The stock has been rising on a successful test that pitted Novo's oral semaglutide drug against the DDP-4 inhibitor Januvia from Merck & Co. and another Novo drug called Victoza, a once-a-week injectable pen used to regulate blood-sugar levels.


Enter a stock symbol to view the stock details.